RxSight, Inc. RXST Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $127.48M-14.0% | $134.48M-3.9% | $142.09M+10.8% | $147.06M+27.7% | $148.31M+46.7% | ||
| $29.3M-29.8% | $31.47M-23.2% | $35.55M-12.2% | $39.53M+1.7% | $41.72M+12.7% | ||
| $98.18M-7.9% | $103.01M+4.1% | $106.53M+21.3% | $107.53M+40.9% | $106.59M+66.3% | ||
| 77%+5.1pp | 76.6%+5.9pp | 75%+6.5pp | 73.1%+6.9pp | 71.9%+8.5pp | ||
| $37.65M+2.6% | $38.55M+12.2% | $38.85M+19.5% | $38.63M+25.6% | $36.7M+22.9% | ||
| $115.87M+8.5% | $112.65M+11.1% | $113.17M+19.9% | $111.43M+26.7% | $106.75M+30.4% | ||
| $153.53M+7.0% | $151.2M+11.3% | $152.02M+19.8% | $150.06M+26.4% | $143.45M+28.4% | ||
| -$55.35M-50.2% | -$48.19M-30.8% | -$45.48M-16.4% | -$42.53M-0.4% | -$36.86M+22.7% | ||
| -43.4%-18.6pp | -35.8%-9.5pp | -32%-1.5pp | -28.9%+7.9pp | -24.9%+22.3pp | ||
| $17K-22.7% | $20K-9.1% | $20K-4.8% | $21K-91.5% | $22K-98.8% | ||
| -$46.59M-75.9% | -$38.88M-41.9% | -$35.66M-16.2% | -$32.18M+12.4% | -$26.49M+40.4% | ||
| $53K-10.2% | $65K+30.0% | $72K— | $75K— | $59K— | ||
| -$46.64M-75.7% | -$38.94M-41.8% | -$35.73M-16.4% | -$32.25M+12.3% | -$26.55M+40.3% | ||
| -36.6%-18.7pp | -29%-9.3pp | -25.1%-1.2pp | -21.9%+10.0pp | -17.9%+26.1pp | ||
| -$1.13-68.7% | -$0.95-31.9% | -$0.88-7.3% | -$0.80+20.8% | -$0.67+46.4% | ||
| -$52.02M-54.7% | -$44.93M-35.0% | -$42.55M-21.7% | -$39.32M-2.7% | -$33.63M+22.6% | ||
| -40.8%-18.1pp | -33.4%-9.6pp | -29.9%-2.7pp | -26.7%+6.5pp | -22.7%+20.3pp | ||
| -$55.35M-50.2% | -$48.19M-30.8% | -$45.48M-16.4% | -$42.53M-0.4% | -$36.86M+22.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is RxSight, Inc.'s revenue?
- RxSight, Inc. (RXST) generated $127.5M in revenue over the trailing twelve months, down 14.1% year over year.
- Is RxSight, Inc. profitable?
- RxSight, Inc. is not currently profitable: it reported a net loss of $46.6M over the trailing twelve months, a -36.6% net margin.
- What are RxSight, Inc.'s profit margins?
- Gross margin is 77.0% and operating margin is -43.4%, with a -36.6% net margin.
- What is RxSight, Inc.'s earnings per share?
- RxSight, Inc.'s diluted EPS over the trailing twelve months is $-1.13.
- Where does RxSight, Inc.'s income statement data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
